A paper from Julian Knight’s group and the UK Genomic Advances in Sepsis Investigators uses an integrated functional genomics approach to uncover differences in the host response to pneumonia, identifying opportunities for personalised treatment.
Image is of Galen of Pergamon, who first described the different inflammatory conditions of the body.
A French documentary on Endometriosis, which includes contrubtions by WTCHG researcher Professor Krina Zondervan, is being broadcast on the 8th of March. French speakers with access to "French 5" can see it at 3.10pm. More information, and pictures, can be found on their facebook page.
As part of the University of Oxford's partnership with The Conversation, centre member George Busby has written an article on how we're using genetic information to track the history of human migration.
Dr Antonia Velayos-Baeza, part of the Monaco lab at the WTCHG, has been interviewed for the latest Nuffield Department of Medicine video series where he speaks about his research.
Dr Zamin Iqbal from the Wellcome Trust Centre for Human Genetics has led the development of a computer program that can quickly analyse bacterial DNA from a patient's infection and predict which antibiotics will work, and which will fail due to drug resistance.
Dr Dianne Newbury, group leader at the WTCHG has been awarded the 'Principle Investigator Prize' from the Nuffield Department of Medicine for her work in engaging the public with science.
The Division of Structural Biology, also based at the WTCHG, was also awarded a special "Challenge Fund" prize of £500 to further develop their public engagement programme
The Nuffield Department of Medicine, of which the WTCHG is a part, have just released a new video about their committment to public engagement.
Engaging the public with research helps empower people, broadens attitudes to academic research, and ensures that the work we do is relevant to society and its wider social concerns. Establishing a dialogue between researchers and the public means that society can benefit more fully from research outputs.
The University of Oxford has signed a collaboration agreement with Oxford University Hospitals NHS Foundation Trust and leading genetic analysis company Genomics plc to carry out a research project focused on the translation of whole genome sequencing into clinical practice.
New palm-sized, MiniION sequencer, costing around $1,000, designed to analyse DNA to help track disease outbreaks, check food and offer ‘the democratisation of sequencing’